CLINICAL-PHARMACOLOGY OF OFLOXACIN

被引：13

作者：

VERHO, M

DAGROSA, EE

MALERCZYK, V

机构：

来源：

INFECTION | 1986年 / 14卷

关键词：

D O I：

10.1007/BF01645199

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S47 / S53

页数：7

共 21 条

[1]

[Anonymous], 1984, CHEMOTHERAPY, V32, P118

[2] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].

BAUERNFEIND, A ;

PETERMULLER, C .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115

[3] A SUMMARY OF CLINICAL PHASE-II AND PHASE-III STUDY RESULTS ON OFLOXACIN (HOE-280) IN EUROPE [J].

BLOMER, R ;

BRUCH, K ;

ZAHLTEN, RN .

INFECTION, 1986, 14 :S102-S107

[4]

CHO N, 1983, 13TH P INT C CHEM VI

[5]

DAGROSA E, 1984, FORTSCHR ANTIMIKR AN, V3, P665

[6]

GOTO S, 1983, 13TH P INT C CHEM VI, V5

[7]

HURWITZ A, SINGLE ASCENDING DOS

[8]

KUMADA T, 1983, 13TH P INT C CHEM VI, V5

[9]

MASUDA G, 1983, 13TH P INT C CHEM VI, V5

[10] ABSORPTION, DISTRIBUTION, METABOLIC-FATE, AND ELIMINATION OF PEFLOXACIN MESYLATE IN MICE, RATS, DOGS, MONKEYS, AND HUMANS [J].

MONTAY, G ;

GOUEFFON, Y ;

ROQUET, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :463-472

← 1 2 3 →